{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:27:50Z","timestamp":1792686470990,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,18]]},"DOI":"10.7759\/cureus.79213","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T12:15:32Z","timestamp":1739880932000},"source":"Crossref","is-referenced-by-count":1,"title":["Medication-Related Osteonecrosis Successfully Treated With Hyperbaric Oxygen Therapy and Conservative Treatment: A Case Report"],"prefix":"10.7759","author":[{"given":"Tougo","family":"Tanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichiro","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritaka","family":"Ohga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Yanagawa-Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Kobori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero SL","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 update. J Oral Maxillofac Surg. 2022, 80:920-43. 10.1016\/j.joms.2022.02.008","journal-title":"J Oral Maxillofac Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-016-0810-7","article-title":"Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw","volume":"35","author":"Yoneda T","year":"2017","unstructured":"Yoneda T, Hagino H, Sugimoto T, et al.. Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw. J Bone Miner Metab. 2017, 35:6-19. 10.1007\/s00774-016-0810-7","journal-title":"J Bone Miner Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2015.09.024","article-title":"Disease stage and mode of therapy are important determinants of treatment outcomes for medication-related osteonecrosis of the jaw","volume":"73","author":"Ruggiero SL","year":"2015","unstructured":"Ruggiero SL, Kohn N. Disease stage and mode of therapy are important determinants of treatment outcomes for medication-related osteonecrosis of the jaw. J Oral Maxillofac Surg. 2015, 73:S94-100. 10.1016\/j.joms.2015.09.024","journal-title":"J Oral Maxillofac Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3191","article-title":"Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: a multicenter retrospective study with propensity score matching analysis","volume":"32","author":"Hayashida S","year":"2017","unstructured":"Hayashida S, Soutome S, Yanamoto S, et al.. Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: a multicenter retrospective study with propensity score matching analysis. J Bone Miner Res. 2017, 32:2022-9. 10.1002\/jbmr.3191","journal-title":"J Bone Miner Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2014.08.016","article-title":"A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ)","volume":"50","author":"Rupel K","year":"2014","unstructured":"Rupel K, Ottaviani G, Gobbo M, et al.. A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Oral Oncol. 2014, 50:1049-57. 10.1016\/j.oraloncology.2014.08.016","journal-title":"Oral Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2015.01.026","article-title":"Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review","volume":"44","author":"Fliefel R","year":"2015","unstructured":"Fliefel R, Tr\u00f6ltzsch M, K\u00fchnisch J, Ehrenfeld M, Otto S. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int J Oral Maxillofac Surg. 2015, 44:568-85. 10.1016\/j.ijom.2015.01.026","journal-title":"Int J Oral Maxillofac Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.1985.0074","article-title":"Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin","volume":"111","author":"Marx RE","year":"1985","unstructured":"Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc. 1985, 111:49-54. 10.14219\/jada.archive.1985.0074","journal-title":"J Am Dent Assoc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2012.04.001","article-title":"What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics","volume":"70","author":"Freiberger JJ","year":"2012","unstructured":"Freiberger JJ, Padilla-Burgos R, McGraw T, et al.. What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics. J Oral Maxillofac Surg. 2012, 70:1573-83. 10.1016\/j.joms.2012.04.001","journal-title":"J Oral Maxillofac Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-023-05410-7","article-title":"Hyperbaric oxygen therapy as an adjunct treatment of periodontitis, MRONJ, and ONJ: a systematic literature review","volume":"28","author":"Heck T","year":"2024","unstructured":"Heck T, Lohana D, Mallela D, et al.. Hyperbaric oxygen therapy as an adjunct treatment of periodontitis, MRONJ, and ONJ: a systematic literature review. Clin Oral Investig. 2024, 28:77. 10.1007\/s00784-023-05410-7","journal-title":"Clin Oral Investig"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.28920\/dhm47.2.131-132","article-title":"Correction to Mathieu D, Marroni A, Kot J: Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Diving Hyperb Med. 2017 Mar; 47(1):24-32","volume":"47","author":"Mathieu D","year":"2017","unstructured":"Mathieu D, Marroni A, Kot J. Correction to Mathieu D, Marroni A, Kot J: Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Diving Hyperb Med. 2017 Mar; 47(1):24-32. Diving Hyperb Med. 2017, 47:131-2. 10.28920\/dhm47.2.131-132","journal-title":"Diving Hyperb Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan AA","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA, et al.. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015, 30:3-23. 10.1002\/jbmr.2405","journal-title":"J Bone Miner Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdsr.2018.12.001","article-title":"Imaging modalities for drug-related osteonecrosis of the jaw (3), positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw","volume":"55","author":"Kitagawa Y","year":"2019","unstructured":"Kitagawa Y, Ohga N, Asaka T, et al.. Imaging modalities for drug-related osteonecrosis of the jaw (3), positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw. Jpn Dent Sci Rev. 2019, 55:65-70. 10.1016\/j.jdsr.2018.12.001","journal-title":"Jpn Dent Sci Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.69226","article-title":"The effectiveness of hyperbaric oxygen therapy on older patients with medication-related osteonecrosis of the jaws: a case series","volume":"16","author":"Kimura T","year":"2024","unstructured":"Kimura T, Kusano K, Sakata KI, Sato J, Kitagawa Y. The effectiveness of hyperbaric oxygen therapy on older patients with medication-related osteonecrosis of the jaws: a case series. Cureus. 2024, 16:e69226. 10.7759\/cureus.69226","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1160774","article-title":"Adverse effects of hyperbaric oxygen therapy: a systematic review and meta-analysis","volume":"10","author":"Zhang Y","year":"2023","unstructured":"Zhang Y, Zhou Y, Jia Y, Wang T, Meng D. Adverse effects of hyperbaric oxygen therapy: a systematic review and meta-analysis. Front Med (Lausanne). 2023, 10:1160774. 10.3389\/fmed.2023.1160774","journal-title":"Front Med (Lausanne)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.22462\/3.4.2017.2","article-title":"Effect of hyperbaric oxygen therapy on blood pressure in patients undergoing treatment","volume":"44","author":"Heyboer Rd M","year":"2017","unstructured":"Heyboer Rd M, Wojcik SM, Smith G, Santiago W. Effect of hyperbaric oxygen therapy on blood pressure in patients undergoing treatment. Undersea Hyperb Med. 2017, 44:93-9. 10.22462\/3.4.2017.2","journal-title":"Undersea Hyperb Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2005.09.001","article-title":"The effects of hyperbaric oxygen treatment on oxidative stress and SCE frequencies in humans","volume":"38","author":"Eken A","year":"2005","unstructured":"Eken A, Aydin A, Sayal A, Ust\u00fcnda\u011f A, Duydu Y, D\u00fcndar K. The effects of hyperbaric oxygen treatment on oxidative stress and SCE frequencies in humans. Clin Biochem. 2005, 38:1133-7. 10.1016\/j.clinbiochem.2005.09.001","journal-title":"Clin Biochem"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.23049","article-title":"Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy","volume":"112","author":"Li B","year":"2011","unstructured":"Li B, Ling Chau JF, Wang X, Leong WF. Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy. J Cell Biochem. 2011, 112:1229-42. 10.1002\/jcb.23049","journal-title":"J Cell Biochem"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2008.00803.x","article-title":"Phase 1 trial of denosumab safety, pharmacokinetics, and pharmacodynamics in Japanese women with breast cancer-related bone metastases","volume":"99","author":"Yonemori K","year":"2008","unstructured":"Yonemori K, Fujiwara Y, Minami H, et al.. Phase 1 trial of denosumab safety, pharmacokinetics, and pharmacodynamics in Japanese women with breast cancer-related bone metastases. Cancer Sci. 2008, 99:1237-42. 10.1111\/j.1349-7006.2008.00803.x","journal-title":"Cancer Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3290\/j.qi.a33528","article-title":"Healing of osteonecrosis of the jaw (ONJ) after discontinuation of denosumab in a patient with bone metastases of colorectal cancer: a case report and hypothesis","volume":"46","author":"Ohga N","year":"2015","unstructured":"Ohga N, Yamazaki Y, Tsuboi K, Kitagawa Y. Healing of osteonecrosis of the jaw (ONJ) after discontinuation of denosumab in a patient with bone metastases of colorectal cancer: a case report and hypothesis. Quintessence Int. 2015, 46:621-6. 10.3290\/j.qi.a33528","journal-title":"Quintessence Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2012.08.439","article-title":"The relationship of denosumab pharmacology and osteonecrosis of the jaws","volume":"114","author":"Malan J","year":"2012","unstructured":"Malan J, Ettinger K, Naumann E, Beirne OR. The relationship of denosumab pharmacology and osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012, 114:671-6. 10.1016\/j.oooo.2012.08.439","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/342640-medication-related-osteonecrosis-successfully-treated-with-hyperbaric-oxygen-therapy-and-conservative-treatment-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T12:15:34Z","timestamp":1739880934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/342640-medication-related-osteonecrosis-successfully-treated-with-hyperbaric-oxygen-therapy-and-conservative-treatment-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.79213","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,18]]}}}